Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel-Reference-Cited by-同舟云学术

Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

Published:2014-02-14 Issue:6b Volume:114 Page:E11-E17
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Nuhn Philipp¹²,Vaghasia Ajay M.¹,Goyal Jatinder¹,Zhou Xian C.¹,Carducci Michael A.¹,Eisenberger Mario A.¹,Antonarakis Emmanuel S.¹

Affiliation:

1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Johns Hopkins University; Baltimore MD USA

2. Department of Urology; Ludwig-Maximilians-Universität; Munich Germany

Funder

National Institutes of Health

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12531/fullpdf

Reference38 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review;Loblaw;Clin Oncol (R Coll Radiol),2013

4. Abiraterone and increased survival in metastatic prostate cancer;Bono;N Engl J Med,2011

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;Bono;Lancet,2010

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-04

2. Therapeutic targeting of tumour myeloid cells;Nature Reviews Cancer;2023-02-06

3. Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease;Journal of Translational Medicine;2023-01-02

4. Prognostic model for prostate cancer based on glycolysis-related genes and non-negative matrix factorization analysis;BIOCELL;2023

5. Revealing the prognostic and clinicopathological significance of systemic immune-inflammation index in patients with different stage prostate cancer: A systematic review and meta-analysis;Frontiers in Medicine;2022-10-31